- Home
- CREV vs APTO Comparison
CREV vs APTO Comparison
Compare CREV & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- APTO
- Stock Information
- Founded
- CREV 2007
- APTO 1986
- Country
- CREV Ireland
- APTO Canada
- Employees
- CREV N/A
- APTO N/A
- Industry
- CREV
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CREV
- APTO Health Care
- Exchange
- CREV Nasdaq
- APTO Nasdaq
- Market Cap
- CREV 7.2M
- APTO 6.8M
- IPO Year
- CREV N/A
- APTO N/A
- Fundamental
- Price
- CREV $2.76
- APTO $3.78
- Analyst Decision
- CREV Strong Buy
- APTO Strong Buy
- Analyst Count
- CREV 1
- APTO 3
- Target Price
- CREV $39.00
- APTO $130.00
- AVG Volume (30 Days)
- CREV 25.5K
- APTO 403.5K
- Earning Date
- CREV 01-01-0001
- APTO 03-25-2025
- Dividend Yield
- CREV N/A
- APTO N/A
- EPS Growth
- CREV N/A
- APTO N/A
- EPS
- CREV N/A
- APTO N/A
- Revenue
- CREV $39,261,077.00
- APTO N/A
- Revenue This Year
- CREV $40.76
- APTO N/A
- Revenue Next Year
- CREV $86.18
- APTO N/A
- P/E Ratio
- CREV N/A
- APTO N/A
- Revenue Growth
- CREV 41.52
- APTO N/A
- 52 Week Low
- CREV $2.00
- APTO $2.39
- 52 Week High
- CREV $22.34
- APTO $51.60
- Technical
- Relative Strength Index (RSI)
- CREV 34.70
- APTO 45.54
- Support Level
- CREV $2.72
- APTO $2.82
- Resistance Level
- CREV $3.79
- APTO $7.80
- Average True Range (ATR)
- CREV 0.22
- APTO 0.44
- MACD
- CREV -0.02
- APTO 0.09
- Stochastic Oscillator
- CREV 4.30
- APTO 57.68
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.